Portal hypertension is abnormally high blood pressure in the portal vein, the large vessel that carries blood from your digestive organs to your liver. It develops when something blocks or restricts blood flow through the liver, forcing pressure to build up in the portal system. The condition is most commonly caused by cirrhosis (scarring of the liver) and is responsible for many of the most serious complications of liver disease, including fluid buildup in the abdomen, internal bleeding, and confusion caused by toxins the liver can no longer filter.
How the Portal Vein System Works
Your portal vein collects blood from your stomach, intestines, spleen, and pancreas and delivers it to the liver for processing. In a healthy liver, blood flows through a network of tiny vessels inside the organ, gets filtered, and exits through the hepatic veins into the general circulation. When disease damages the liver or obstructs this pathway, resistance increases and pressure backs up into the portal system.
Normal pressure in the portal system is low. Portal hypertension is formally measured using a technique that calculates the pressure difference between the portal vein and the hepatic veins. A gradient above 5 mmHg indicates portal hypertension exists. Above 10 mmHg, it becomes “clinically significant,” meaning the risk of serious complications like bleeding, fluid retention, and liver-related brain fog rises sharply. Above 12 mmHg, the risk of bleeding from swollen veins in the esophagus increases further, and above 20 mmHg, the risk of dying from such a bleed becomes high.
What Causes It
Causes are grouped by where the obstruction or problem occurs relative to the liver.
Problems Before the Liver
Blood clots in the portal or splenic veins, tumors pressing on these veins, and abnormal connections between arteries and veins can all raise portal pressure before blood even reaches the liver. These “prehepatic” causes are less common but can occur in people without any liver disease.
Problems Inside the Liver
This is by far the most common category. Cirrhosis, from any cause, tops the list. Alcohol-related liver disease, chronic hepatitis B and C, and fatty liver disease all lead to scarring that narrows the tiny vessels inside the liver. Other intrahepatic causes include parasitic infections like schistosomiasis (a major cause worldwide), sarcoidosis, congenital liver fibrosis, and toxic exposures to substances like arsenic or vinyl chloride. Veno-occlusive disease, where the smallest veins inside the liver become blocked, is another cause seen after certain drug treatments or bone marrow transplants.
Problems After the Liver
Anything that blocks blood from leaving the liver can also raise portal pressure. Budd-Chiari syndrome, where clots form in the hepatic veins, is the classic example. Heart conditions that increase pressure on the right side of the heart, such as constrictive pericarditis or severe tricuspid valve problems, can back pressure all the way into the portal system. Blockages in the large vein that returns blood to the heart (the inferior vena cava) from tumors, clots, or structural abnormalities also qualify.
Symptoms and Warning Signs
Portal hypertension itself doesn’t cause symptoms early on. What you feel are the consequences of the pressure building up over time. Common symptoms include persistent fatigue, weakness, loss of appetite, unintentional weight loss, and jaundice (yellowing of the skin and eyes). Dark urine and swelling in the legs may also appear.
The more distinctive signs come from specific complications:
- Ascites: Fluid accumulates in the abdomen, causing visible swelling, discomfort, and sometimes difficulty breathing. This is one of the most common reasons portal hypertension gets diagnosed in the first place.
- Varices: When portal pressure rises, blood finds alternative routes around the liver. These detour vessels, called varices, often form in the esophagus and stomach. They have thin walls and can rupture, causing life-threatening internal bleeding. The higher the pressure, the larger these vessels grow and the thinner their walls become.
- Splenomegaly: The spleen enlarges because blood backs up into it. An enlarged spleen can destroy blood cells faster than normal, leading to low platelet counts and easy bruising.
- Hepatic encephalopathy: Toxins that the liver normally clears, particularly ammonia, bypass the organ through those detour vessels and reach the brain. This can cause personality changes, confusion, disrupted sleep patterns, and in severe cases, coma.
- Spider angiomas: Small, spider-shaped blood vessels may appear on the skin, particularly the chest and face.
How It Is Diagnosed
The gold standard for measuring portal hypertension is catheterization of the hepatic vein to directly measure the pressure gradient. This is done by threading a thin catheter through the neck vein into the liver’s veins. It’s accurate but invasive, so doctors increasingly rely on non-invasive alternatives.
Liver stiffness measurement using ultrasound elastography has become a widely used screening tool. This painless test bounces sound waves through the liver and calculates how stiff the tissue is, since stiffer tissue correlates with higher portal pressure. When liver stiffness is low (under 15 kPa) and platelet counts are normal (above 150,000 per microliter), clinically significant portal hypertension can be ruled out with over 90% confidence. Conversely, a liver stiffness reading of 25 kPa or higher in people with cirrhosis from alcohol or viral hepatitis strongly suggests clinically significant portal hypertension.
Spleen stiffness measurement is another emerging approach. When spleen stiffness exceeds 40 to 45 kPa, clinically significant portal hypertension is likely present. Studies show spleen stiffness has a sensitivity and specificity around 85% for detecting the condition. Standard imaging with ultrasound, CT scans, or MRI can also reveal indirect signs: an enlarged portal vein, an enlarged spleen, visible collateral vessels around the liver, or ascites fluid in the abdomen. An upper endoscopy is used to look directly for varices in the esophagus and stomach.
Treatment Options
Treatment focuses on lowering portal pressure and preventing or managing complications. The approach depends on whether the condition is still “compensated” (stable, no major complications yet) or “decompensated” (complications like ascites or variceal bleeding have developed).
Medications to Lower Pressure
Non-selective beta-blockers are the first-line therapy. These medications work by reducing both heart rate and blood flow into the portal system. Carvedilol is now the preferred choice for people with compensated cirrhosis because it lowers portal pressure more effectively than older options, has shown survival benefits compared to no treatment, and tends to be better tolerated. For people who can’t take carvedilol, propranolol and nadolol are alternatives. These drugs are recommended not just for treating varices but for preventing the first episode of decompensation in anyone with clinically significant portal hypertension.
Endoscopic Band Ligation
If you have high-risk varices but can’t tolerate beta-blockers, doctors can place small rubber bands around the swollen veins during an endoscopy to cut off their blood supply and prevent bleeding. This is also used during acute bleeding episodes to stop hemorrhage directly.
TIPS Procedure
When medications and endoscopic treatments aren’t enough, a procedure called TIPS (transjugular intrahepatic portosystemic shunt) may be recommended. A radiologist creates a small channel inside the liver connecting the portal vein to the hepatic vein, giving blood a shortcut through the liver and significantly dropping portal pressure. TIPS is particularly useful for people with ascites that keeps coming back despite treatment (three or more large-volume drainage procedures in a year), and for bleeding that doesn’t respond to other therapies. In high-risk patients who come in with active variceal bleeding, early TIPS placement within 72 hours (ideally within 24 hours) has been shown to improve survival.
Liver Transplant
For people with advanced liver disease driving the portal hypertension, transplant remains the only definitive cure. It replaces the damaged liver entirely, resolving the underlying cause of the elevated pressure.
What Happens During a Variceal Bleed
A ruptured varix is a medical emergency. You might vomit blood or pass dark, tarry stools. The experience typically involves rapid admission to intensive care, where the immediate priorities are stabilizing blood pressure and replacing lost blood. A restrictive transfusion approach is standard, aiming to keep hemoglobin between 7 and 9 g/dL, because over-transfusing can actually worsen portal pressure.
Medications that constrict the blood vessels feeding the portal system are started immediately, even before the bleeding source is confirmed. An upper endoscopy is performed within 12 hours to locate and treat the bleeding vein, usually with band ligation. Antibiotics are started right away and continued for up to 7 days because people with cirrhosis and gastrointestinal bleeding face a high risk of infection. If the combination of drugs and endoscopy fails to stop the bleed, emergency TIPS is the next step.
Prognosis and Staging
Outcomes depend heavily on whether the disease is compensated or decompensated. Cirrhosis with portal hypertension progresses through recognizable stages, each carrying different risks.
In stage 1, where there’s compensated cirrhosis without varices, the one-year mortality is about 3.4%. In stage 2, compensated cirrhosis with varices, it rises to 7.3%. Once decompensation occurs, the picture changes dramatically. Stage 3, marked by the development of ascites, carries a one-year mortality around 22%. Stage 4, defined by variceal hemorrhage, has a one-year mortality of roughly 18%. Overall, one-year mortality jumps from about 5% in compensated patients to over 20% in decompensated patients.
The presence of ascites appears to be a particularly important marker. Among decompensated patients, those with ascites had a one-year mortality of 21.5%, compared to 14.1% for those whose decompensation involved only variceal bleeding without ascites. This is one reason current guidelines emphasize starting beta-blockers early, even before complications develop, to try to keep patients in the compensated stage as long as possible.